- Home
- CPRX vs FSM Comparison
CPRX vs FSM Comparison
Compare CPRX & FSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | FSM |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 2006 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CPRX | FSM |
|---|---|---|
| Price | $23.64 | $13.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $32.50 | $14.00 |
| AVG Volume (30 Days) | 1.1M | ★ 7.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 1.68 | N/A |
| Revenue | ★ $119,072,803.00 | N/A |
| Revenue This Year | $7.14 | $35.26 |
| Revenue Next Year | $7.68 | N/A |
| P/E Ratio | ★ $13.68 | $14.10 |
| Revenue Growth | ★ 16.39 | N/A |
| 52 Week Low | $19.05 | $4.13 |
| 52 Week High | $26.56 | $13.84 |
Technical Indicators
Market Signals| Indicator | CPRX | FSM |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 66.76 |
| Support Level | $22.25 | $9.58 |
| Resistance Level | $24.81 | N/A |
| Average True Range (ATR) | 0.97 | 0.74 |
| MACD | -0.11 | 0.27 |
| Stochastic Oscillator | 52.61 | 94.02 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.